減量薬の世界市場レポート 2025年

減量薬市場規模は、今後数年間で飛躍的な成長が見込まれます。2029年にはCAGR41.7％で170億8,000万米ドルに成長します。予測期間の成長は、高齢者人口の増加、ソーシャルメディアの影響、フィットネスとウェルネスの動向、美に対する文化的認識、製薬業界の投資などに起因すると考えられます。予測期間の主な動向には、技術の進歩、非処方箋ソリューションへの注力、個別化医療、併用療法、製品革新、市販後調査などが含まれます。

減量薬市場の主要企業は、患者により良いサービスを提供するため、革新的な製品の開発に注力しています。その一例がゼップバウンド（チルゼパチド）注射剤で、週1回注射可能な二重グルコース依存性インスリン分泌促進ポリペプチド（GIP）とグルカゴン-ペプチド-1（GLP-1）受容体作動薬です。2023年11月、米国の製薬会社イーライリリー・アンド・カンパニーは、過体重または肥満で少なくとも1つの体重関連疾患を有する成人の慢性的な体重管理を適応症とするtirzepatide注射剤（Zepbound）のFDA承認を取得しました。ゼップバウンドは、GIP受容体とGLP-1受容体の両方を活性化する、FDAが承認した最初で唯一の肥満症治療薬であり、商業的成功の可能性を示しています。

2023年12月、スイスのヘルスケア企業ロシュ・ホールディングAGは、カーモット・セラピューティクス社を27億米ドルで買収しました。この戦略的買収により、ロシュは第2相臨床試験段階にある注射剤と第1相臨床試験段階にある1日1錠剤を含む2つの肥満症治療薬候補を獲得しました。この買収は、競合が激しく成長中の肥満症治療薬市場におけるロシュの地位を強化することを目的としています。カーモット・セラピューティクス社は米国を拠点とする臨床段階のバイオテクノロジー企業で、肥満と糖尿病の疾患修飾療法の発見と開発を専門としています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界減量薬PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の減量薬市場：成長率分析
• 世界の減量薬市場の実績：規模と成長, 2019-2024
• 世界の減量薬市場の予測：規模と成長, 2024-2029, 2034F
• 世界減量薬総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の減量薬市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 液体
• タブレット
• カプセル
• 世界の減量薬市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• オンライン薬局
• 世界の減量薬市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 減量補助
• 脂肪吸収阻害剤
• 代謝促進剤
• 世界の減量薬市場、液体のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• シロップ
• ソリューション
• サスペンション
• 世界の減量薬市場、タブレットのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 即効性錠剤
• 徐放性錠剤
• 世界の減量薬市場、カプセルのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ハードカプセル
• ソフトジェルカプセル

第7章 地域別・国別分析

• 世界の減量薬市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の減量薬市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 減量薬市場：競合情勢
• 減量薬市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Roche Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Bristol Myers Squibb
• Sanofi S.A.
• AstraZeneca plc
• LG Chem
• GlaxoSmithKline
• Takeda Pharmaceutical Company
• Eli Lilly and Company
• Bayer AG
• Amgen Inc.
• Boehringer Ingelheim group
• Novo Nordisk A/S
• Merck KGaA
• Teva Pharmaceutical Industries Ltd.
• Hisun Pharmaceutical
• Taj Pharmaceuticals Ltd

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 減量薬市場2029：新たな機会を提供する国
• 減量薬市場2029：新たな機会を提供するセグメント
• 減量薬市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Weight loss drugs refer to pharmaceutical substances designed to reduce appetite and food cravings, ultimately leading to a decrease in calorie intake and subsequent weight loss. These drugs undergo approval from the U.S. Food and Drug Administration (FDA) and are prescribed by healthcare professionals to treat individuals suffering from obesity or those who are overweight and have accompanying weight-related medical conditions such as high blood pressure, type 2 diabetes, or high cholesterol.

Weight loss drugs come in various forms, with the main types being liquid, tablets, and capsules. Weight loss liquids refer to formulations designed to assist in weight management and the reduction of body weight. These liquids are available through different distribution channels, including hospital pharmacies, retail pharmacies, and online pharmacies. They may serve various purposes, such as aiding in weight reduction, acting as fat absorption inhibitors, or boosting metabolism.

The weight loss drugs market size has grown exponentially in recent years. It will grow from $1.94 billion in 2023 to $2.87 billion in 2024 at a compound annual growth rate (CAGR) of 47.8%. The growth observed in the historical period can be attributed to several factors, including the increasing rates of obesity, changes in lifestyle, heightened awareness and education about weight-related issues, early diagnosis of medical conditions, and a general rise in healthcare expenditure. These factors collectively contributed to a greater demand for weight loss drugs as individuals sought solutions to address and manage weight-related concerns during the historical period.

The weight loss drugs market size has grown exponentially in recent years. It will grow from $2.87 billion in 2024 to $4.23 billion in 2025 at a compound annual growth rate (CAGR) of 47.6%. The growth in the historic period can be attributed to increasing obesity rates, lifestyle changes, awareness and education, early diagnosis of medical conditions, rising healthcare expenditure.

The weight loss drugs market size is expected to see exponential growth in the next few years. It will grow to $17.08 billion in 2029 at a compound annual growth rate (CAGR) of 41.7%. The growth in the forecast period can be attributed to increasing geriatric population, social media influence, fitness and wellness trends, cultural perception of beauty, pharmaceutical industry investments. Major trends in the forecast period include technological advancements, focus on non-prescription solutions, personalized medicine, combination therapies, product innovation, post-market surveillance.

Major companies in the weight loss drug market are focusing on the development of innovative products to better serve patients. One such example is Zepbound (tirzepatide) injection, a once-weekly injectable dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-such as peptide-1 (GLP-1) receptor agonist. In November 2023, Eli Lilly and Company, a US-based pharmaceutical company, received FDA approval for tirzepatide injection (Zepbound) for chronic weight management in adults with overweight or obesity and at least one weight-related condition. Zepbound stands out as the first and only FDA-approved obesity treatment that activates both GIP and GLP-1 receptors, showing potential for commercial success.

In December 2023, Roche Holding AG, a Switzerland-based healthcare company, successfully acquired Carmot Therapeutics Inc. for $2.7 billion. This strategic acquisition granted Roche access to two obesity drug candidates, including an injectable ready for phase 2 clinical trials and a daily pill version in phase 1 trials. The acquisition aimed to strengthen Roche's position in the competitive and growing obesity drug market. Carmot Therapeutics Inc., a US-based clinical-stage biotechnology company, specializes in the discovery and development of disease-modifying therapies for obesity and diabetes.

Major companies operating in the weight loss drugs market report are Pfizer Inc., Roche, Merck & Co., AbbVie Inc., Novartis AG, Bristol Myers Squibb, Sanofi S.A., AstraZeneca PLC, LG Chem, GlaxoSmithKline, Takeda Pharmaceutical Company, Eli Lilly and Company, Bayer AG, Amgen Inc., Boehringer Ingelheim group, Novo Nordisk A/S, Merck KGaA, Teva Pharmaceutical Industries Ltd., Hisun Pharmaceutical, Taj Pharmaceuticals Ltd., Zhongshan Pharmaceutical Co. Ltd., Dm Pharma, Lunan Pharmaceutical Group Corporation, Wolfson Berg Ltd., Swiss Research Labs Ltd.

North America was the largest region in the Weight Loss Drugs market in 2024. The regions covered in the weight loss drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the weight loss drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The weight loss drugs market consists of sales of appetite suppressants, fat absorption inhibitors, and metabolism boosters. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Weight Loss Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on weight loss drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for weight loss drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The weight loss drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Liquid; Tablets; Capsules
• 2) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy
• 3) By Application: Weight-Reducing Aid; Fat Absorption Inhibitors; Metabolic Boosters
• Subsegments:
• 1) By Liquid: Syrups; Solutions; Suspensions
• 2) By Tablets: Immediate-Release Tablets; Extended-Release Tablets
• 3) By Capsules: Hard Capsules; Softgel Capsules
• Companies Mentioned: Pfizer Inc.; Roche; Merck & Co.; AbbVie Inc.; Novartis AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Weight Loss Drugs Market Characteristics

3. Weight Loss Drugs Market Trends And Strategies

4. Weight Loss Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Weight Loss Drugs Growth Analysis And Strategic Analysis Framework

• 5.1. Global Weight Loss Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Weight Loss Drugs Market Growth Rate Analysis
• 5.4. Global Weight Loss Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Weight Loss Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Weight Loss Drugs Total Addressable Market (TAM)

6. Weight Loss Drugs Market Segmentation

• 6.1. Global Weight Loss Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Liquid
• Tablets
• Capsules
• 6.2. Global Weight Loss Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• 6.3. Global Weight Loss Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Weight-Reducing Aid
• Fat Absorption Inhibitors
• Metabolic Boosters
• 6.4. Global Weight Loss Drugs Market, Sub-Segmentation Of Liquid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Syrups
• Solutions
• Suspensions
• 6.5. Global Weight Loss Drugs Market, Sub-Segmentation Of Tablets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immediate-Release Tablets
• Extended-Release Tablets
• 6.6. Global Weight Loss Drugs Market, Sub-Segmentation Of Capsules, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hard Capsules
• Softgel Capsules

7. Weight Loss Drugs Market Regional And Country Analysis

• 7.1. Global Weight Loss Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Weight Loss Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Weight Loss Drugs Market

• 8.1. Asia-Pacific Weight Loss Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Weight Loss Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Weight Loss Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Weight Loss Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Weight Loss Drugs Market

• 9.1. China Weight Loss Drugs Market Overview
• 9.2. China Weight Loss Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Weight Loss Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Weight Loss Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Weight Loss Drugs Market

• 10.1. India Weight Loss Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Weight Loss Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Weight Loss Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Weight Loss Drugs Market

• 11.1. Japan Weight Loss Drugs Market Overview
• 11.2. Japan Weight Loss Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Weight Loss Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Weight Loss Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Weight Loss Drugs Market

• 12.1. Australia Weight Loss Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Weight Loss Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Weight Loss Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Weight Loss Drugs Market

• 13.1. Indonesia Weight Loss Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Weight Loss Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Weight Loss Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Weight Loss Drugs Market

• 14.1. South Korea Weight Loss Drugs Market Overview
• 14.2. South Korea Weight Loss Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Weight Loss Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Weight Loss Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Weight Loss Drugs Market

• 15.1. Western Europe Weight Loss Drugs Market Overview
• 15.2. Western Europe Weight Loss Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Weight Loss Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Weight Loss Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Weight Loss Drugs Market

• 16.1. UK Weight Loss Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Weight Loss Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Weight Loss Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Weight Loss Drugs Market

• 17.1. Germany Weight Loss Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Weight Loss Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Weight Loss Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Weight Loss Drugs Market

• 18.1. France Weight Loss Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Weight Loss Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Weight Loss Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Weight Loss Drugs Market

• 19.1. Italy Weight Loss Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Weight Loss Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Weight Loss Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Weight Loss Drugs Market

• 20.1. Spain Weight Loss Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Weight Loss Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Weight Loss Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Weight Loss Drugs Market

• 21.1. Eastern Europe Weight Loss Drugs Market Overview
• 21.2. Eastern Europe Weight Loss Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Weight Loss Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Weight Loss Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Weight Loss Drugs Market

• 22.1. Russia Weight Loss Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Weight Loss Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Weight Loss Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Weight Loss Drugs Market

• 23.1. North America Weight Loss Drugs Market Overview
• 23.2. North America Weight Loss Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Weight Loss Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Weight Loss Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Weight Loss Drugs Market

• 24.1. USA Weight Loss Drugs Market Overview
• 24.2. USA Weight Loss Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Weight Loss Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Weight Loss Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Weight Loss Drugs Market

• 25.1. Canada Weight Loss Drugs Market Overview
• 25.2. Canada Weight Loss Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Weight Loss Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Weight Loss Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Weight Loss Drugs Market

• 26.1. South America Weight Loss Drugs Market Overview
• 26.2. South America Weight Loss Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Weight Loss Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Weight Loss Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Weight Loss Drugs Market

• 27.1. Brazil Weight Loss Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Weight Loss Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Weight Loss Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Weight Loss Drugs Market

• 28.1. Middle East Weight Loss Drugs Market Overview
• 28.2. Middle East Weight Loss Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Weight Loss Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Weight Loss Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Weight Loss Drugs Market

• 29.1. Africa Weight Loss Drugs Market Overview
• 29.2. Africa Weight Loss Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Weight Loss Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Weight Loss Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Weight Loss Drugs Market Competitive Landscape And Company Profiles

• 30.1. Weight Loss Drugs Market Competitive Landscape
• 30.2. Weight Loss Drugs Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Roche Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck & Co. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Weight Loss Drugs Market Other Major And Innovative Companies

• 31.1. Bristol Myers Squibb
• 31.2. Sanofi S.A.
• 31.3. AstraZeneca plc
• 31.4. LG Chem
• 31.5. GlaxoSmithKline
• 31.6. Takeda Pharmaceutical Company
• 31.7. Eli Lilly and Company
• 31.8. Bayer AG
• 31.9. Amgen Inc.
• 31.10. Boehringer Ingelheim group
• 31.11. Novo Nordisk A/S
• 31.12. Merck KGaA
• 31.13. Teva Pharmaceutical Industries Ltd.
• 31.14. Hisun Pharmaceutical
• 31.15. Taj Pharmaceuticals Ltd

32. Global Weight Loss Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Weight Loss Drugs Market

34. Recent Developments In The Weight Loss Drugs Market

35. Weight Loss Drugs Market High Potential Countries, Segments and Strategies

• 35.1 Weight Loss Drugs Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Weight Loss Drugs Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Weight Loss Drugs Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer